scholarly journals Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease

2010 ◽  
Vol 30 (11) ◽  
pp. 2264-2276 ◽  
Author(s):  
Dawn M. Waterworth ◽  
Sally L. Ricketts ◽  
Kijoung Song ◽  
Li Chen ◽  
Jing Hua Zhao ◽  
...  
PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e46385 ◽  
Author(s):  
Fumihiko Takeuchi ◽  
Masato Isono ◽  
Tomohiro Katsuya ◽  
Mitsuhiro Yokota ◽  
Ken Yamamoto ◽  
...  

2014 ◽  
Vol 3 (3) ◽  
pp. 206
Author(s):  
P Srilakshmi ◽  
MF Gopinath ◽  
MVijaya Bhaskar ◽  
K Rambabu ◽  
GSrinivasa Reddy

PEDIATRICS ◽  
1962 ◽  
Vol 29 (4) ◽  
pp. 566-578
Author(s):  
George Bialkin ◽  
Saul Zucker ◽  
Burton S. Sklarin ◽  
Kurt Hirschhorn ◽  
Murray Davidson

A family consisting of a mother and father, heterozygous for idiopathic hyperlipemia, and their four offspring, one heterozygous and three homozygous for the disease, are described. In addition, a fifth child who is heterozygous, born of same mother but by another incompletely studied father, is presented. The genetics of the disease in this family, and also in the general population, with emphasis on diagnosis and prognosis in heterozygotes is discussed. The interrelationship of various lipid components in serum and their metabolism are briefly reviewed. The possible defective mechanisms in hyperlipemia, the techniques for deciding on the specific defect, and their application to the members of this family are reviewed. The effect of heparin, nicotinic acid, and fat-free diets in the homozygous members of the family are evaluated and their therapeutic applications are discussed. The symptomatology, possible pathologic physiology, relationship to lipid levels in serum and occurrence of abdominal crises in some of the homozygous members of this family are pointed out. The relationship of cholesterol and triglyceride levels in serum to, and the significance of, idiopathic hyperlipemia in the genesis of, atherosclerosis and coronary artery disease is elucidated.


Author(s):  
Igrid García‐González ◽  
Gerardo Pérez‐Mendoza ◽  
Alberto Solís‐Cárdenas ◽  
Jorge Flores‐Ocampo ◽  
Luis Fernando Herrera‐Sánchez ◽  
...  

Author(s):  
Gilberto Vargas-Alarcón ◽  
Oscar Pérez-Méndez ◽  
Rosalinda Posadas-Sánchez ◽  
Marco A. Peña-Duque ◽  
Marco A. Martínez-Ríos ◽  
...  

2019 ◽  
Author(s):  
Pietari Ripatti ◽  
Joel T Rämö ◽  
Nina J Mars ◽  
Sanni Söderlund ◽  
Christian Benner ◽  
...  

AbstractBackgroundHyperlipidemia is a highly heritable risk factor for coronary artery disease (CAD). Monogenic familial hypercholesterolemia associates with higher increase in CAD risk than expected from a single LDL-C measurement, likely due to lifelong cumulative exposure to high LDL-C. It remains unclear to what extent a high polygenic load of LDL-C or TG-increasing variants associates with increased CAD risk.Methods and ResultsWe derived polygenic risk scores (PRS) with ∼6M variants for LDL-C and TG with weights from a UK biobank-based genome-wide association study with ∼500K samples. We evaluated the impact of polygenic hypercholesterolemia and hypertriglyceridemia to lipid levels in 27 039 individuals from the FINRISK cohort, and to CAD risk in 135 300 individuals (13 695 CAD cases) from the FinnGen project.In FINRISK, LDL-C ranged from 2.83 (95% CI 2.79-2.89) to 3.80 (3.72-3.88) and TG from 0.99 (0.95-1.01) to 1.52 (1.48-1.58) mmol/l between the lowest and highest 5% of the respective PRS distributions. The corresponding CAD prevalences ranged from 8.2% to 12.7% for the LDL-C PRS and from 8.2% to 12.1% for the TG PRS in FinnGen. Furthermore, CAD risk was 1.36-fold higher (OR, 95% CI 1.24-1.49) for the LDL-C PRS and 1.31-fold higher (1.20-1.44) for the TG PRS for those with the PRS >95th percentile vs those without. These estimates were only slightly attenuated when adjusting for a CAD PRS (OR 1.26 [95% CI 1.15-1.39] for LDL-C and 1.21 [1.10-1.32] for TG PRS).ConclusionsThe CAD risk associated with a high polygenic load for lipid-increasing variants was proportional to their impact on lipid levels and mostly independent of a CAD PRS. In contrast with a PRS for CAD, the lipid PRSs point to known and directly modifiable risk factors providing more direct guidance for clinical translation.


Sign in / Sign up

Export Citation Format

Share Document